<DOC>
	<DOCNO>NCT01236469</DOCNO>
	<brief_summary>The purpose study ass probable benefit CryoValve SG Aortic Human Heart Valve use pediatric patient aortic valve replacement .</brief_summary>
	<brief_title>CryoValve® SG Aortic Human Heart Valve Combination Study</brief_title>
	<detailed_description>The CryoValve SG aortic human heart valve recover deceased human donor , treat SynerGraft® ( SG ) process , design reduce donor cell present graft . The valve cryopreserved storage use . Removing cell heart valve show reduce component immune response implant compare standard allograft valve . However , know affect long-term durability valve .</detailed_description>
	<mesh_term>Aortic Valve Stenosis</mesh_term>
	<mesh_term>Aortic Valve Insufficiency</mesh_term>
	<criteria>Patients implant CryoValve SGAV aortic valve replacement . Patients ≤ 21 year age time implant . Patients CryoValve SGAV use patch nonvalved conduit . Patients implanted CryoValve SGAV pulmonary valve replacement . Patients ≥ 22 year age time implant .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>27 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Aortic Valve</keyword>
</DOC>